1,964
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Healthcare costs of patients with cancer stratified by Khorana score risk levels

, , , , ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon & show all
Pages 866-873 | Received 16 Mar 2021, Accepted 24 Jun 2021, Published online: 14 Jul 2021

Figures & data

Figure 1. Patient disposition. Abbreviations. AC, anticoagulant; AF, atrial fibrillation; VTE, venous thromboembolism. 1Cancer treatment included non-radiation and radiation therapies. 2Defined as a procedure code for major surgery, abdominopelvic surgery, and neurosurgery or orthopedic surgery during an inpatient stay.

Figure 1. Patient disposition. Abbreviations. AC, anticoagulant; AF, atrial fibrillation; VTE, venous thromboembolism. 1Cancer treatment included non-radiation and radiation therapies. 2Defined as a procedure code for major surgery, abdominopelvic surgery, and neurosurgery or orthopedic surgery during an inpatient stay.

Table 1. Demographic and clinical characteristics.

Figure 2. All-cause total healthcare costs per patient per month up to 12 months of follow-up. Abbreviation. KS, Khorana score. *Defines p-value <.05. 1Calculated using linear regressions. p-values were obtained using nonparametric bootstraps with 499 replications. 2Adjusted for the following variables: sex, age, index year, region, insurance type, Charlson comorbidity index, baseline healthcare resource use and costs, and comorbidities with proportions ≥5% at baseline (e.g. hypertension and chronic pulmonary disease).

Figure 2. All-cause total healthcare costs per patient per month up to 12 months of follow-up. Abbreviation. KS, Khorana score. *Defines p-value <.05. 1Calculated using linear regressions. p-values were obtained using nonparametric bootstraps with 499 replications. 2Adjusted for the following variables: sex, age, index year, region, insurance type, Charlson comorbidity index, baseline healthcare resource use and costs, and comorbidities with proportions ≥5% at baseline (e.g. hypertension and chronic pulmonary disease).

Table 2. Healthcare costs per patient per month up to 12 months of follow-up.

Figure 3. VTE-related total healthcare costs per patient per month up to 12 months of follow-up. Abbreviation. KS, Khorana score; VTE, venous thromboembolism. *Defines p-value <.05. 1Calculated using linear regressions. p-values were obtained using nonparametric bootstraps with 499 replications. 2Adjusted for the following variables: sex, age, index year, region, insurance type, Charlson comorbidity index, baseline healthcare resource use and costs, and comorbidities with proportions ≥5% at baseline (e.g. hypertension and chronic pulmonary disease).

Figure 3. VTE-related total healthcare costs per patient per month up to 12 months of follow-up. Abbreviation. KS, Khorana score; VTE, venous thromboembolism. *Defines p-value <.05. 1Calculated using linear regressions. p-values were obtained using nonparametric bootstraps with 499 replications. 2Adjusted for the following variables: sex, age, index year, region, insurance type, Charlson comorbidity index, baseline healthcare resource use and costs, and comorbidities with proportions ≥5% at baseline (e.g. hypertension and chronic pulmonary disease).